Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...
The Montgomery Advertiser on MSN3d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
3don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
One potential solution is HIV self-testing, which would allow for rapid identification and treatment. Identifying HIV cases is the first step in addressing clusters, and quickly learning one’s ...
In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...
Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback